Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)

计划入组 18 人 · 首次发布于 2020 年 11 月 13 日

Transplantation of Autologous RPE Versus Translocation of Autologous RPE and Choroid in AMD

计划入组 40 人 · 首次发布于 2006 年 11 月 20 日

Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.

计划入组 54 人 · 首次发布于 2024 年 5 月 1 日

embryonic stem cell therapy

CytoRet

ASP-7317

Cell Therapy Ltd.

United Kingdom

Juventas Cell Therapy Ltd

China

Shanghai Cell Therapy Research Institute

China

Cirrus Therapeutics Expands to Singapore, Unveils Novel RPE Cell Therapy for Geographic Atrophy

Eyestem Receives CDSCO Approval for Phase 2 Trial of Stem Cell Therapy for Dry AMD

NIH Scientists Develop Novel Surgical Technique to Enhance Cell Therapy for Dry Age-Related Macular Degeneration